Abstract
The auditory brainstem response (ABR) test provides information about the inner ear (cochlea) and the central pathways for hearing. The ABR reflects the electrical responses of both the cochlear ganglion neurons and the nuclei of the central auditory pathway to sound stimulation (Zhou et al., 2006; Burkard et al., 2007). The ABR contains 5 identifiable wave forms, labeled as I-V. Wave I represents the summated response from the spiral ganglion and auditory nerve while waves II-V represent responses from the ascending auditory pathway. The ABR is recorded via electrodes placed on the scalp of an anesthetized animal. ABR thresholds refer to the lowest sound pressure level (SPL) that can generate identifiable electrical response waves.
This protocol describes the process of measuring the ABR of small rodents (mouse, rat, guinea pig, etc.), including anesthetizing the mouse, placing the electrodes on the scalp, recording click and tone burst stimuli and reading the obtained waveforms for ABR threshold values. As technology continues to evolve, ABR will likely provide more qualitative and quantitative information regarding the function of the auditory nerve and brainstem pathways involved in hearing.
Materials and Reagents
1 ml insulin syringe (Thermo Fisher Scientific, BD, catalog number: 22-253-260)
Precision Glide Needles (30 G × 1/2) (BD, catalog number: 305106)
Disposable monopolar needle electrodes for electromyography (Rochester Electro Medical, catalog number: 016386-0)
- Ketamine hydrochloride:
- Ketaset (Ketamine HCl Injection) (Drugs, catalog number: NDC-0856-2013-01)
- Henry Schein (100 mg/ml solution) (NSN, catalog number: 304401)
Xylazine hydrochloride (Sedative and Analgesic solution) (20 mg/ml solution) (LLOYD, AnaSed INJECTION, catalog number: 139-236)
Sterile bi-distilled water
Providone-iodine 5% (Betadine) antiseptic-Microbicide solution (purchased from any pharmacy)
Dexamethasone ophthalmic ointment (TobraDex) (Alcon)
70% Ethanol (Surface disinfectant)
Mixture of ketamine hydrochloride and xylazine hydrochloride (see Recipes)
Equipment
Computer with BioSig32 Windows Application Installed
TDT BioSigIII system (TDT)
TD speakers (TDT)
Sound proof chamber (Industrial Acoustics Company, Controlled Acoustical Environment)
Non-Electric Heating Pad (to maintain animal body temperature during the test) (Braintree Scientific, Deltaphase Isothermal Pad, model: 39DP)
CONAIR Moist Electric Heating Pad (to maintain animal body temperature during the recovery) (Amazon)
Rectal Probe for body temperature monitoring (Physitemp Instruments, model: Thermalert TH-5 physitemp)
Clean empty cages
Tweezers style 5 (Ted Pella, catalog number: 5665)
Software
BioSig32 software (coming with the TDT BioSig III system)
Procedure
All procedures and animal handling described in this protocol should be done according to approved national ethical guidelines and complied with all protocol requirements of the Institutional Animal Care and Use Committee.
Notes:
Appropriate site-specific IACUC approvals are required to perform the following procedures.
The onset of hearing in mice is around postnatal day 12 (P12), so the hearing test can be performed on mouse older than P12.
The FVB mouse strain was used in this protocol but any mouse strain can be used with this protocol.
- Preparation
-
The animal is anesthetized with an intraperitoneal injection of a mixture of ketamine hydrochloride (Ketaset 100 mg/kg) and xylazine hydrochloride (Xyla-Ject 10 mg/kg) using the 1 ml insulin syringe with the precision glide needle.Notes:
- When working with mice, gloves and lab coat should be worn at all times.
- Additionally, for less experienced users, a heavy glove may be worn when injecting older mice to protect from biting.
- It is advised to use only ketamine and xylazine solution for anesthesia when testing hearing because this drug combination provides stable ABR thresholds.
-
After injection the animal is placed in an isolated clean and warm cage (~37 °C) using an electric heating pad or other hearing device.Note: No other awake animals should be with an anesthetized mouse.
- The mouse will be ready for testing within ~2-5 min. Appropriate levels of anesthesia can be tested with a stimulus such as a toe pinch.
- Place the mouse on a preheated non-electric heating pad (~37 °C) in a soundproof chamber.
- Monitor the body temperature with a rectal probe throughout recording.
- Cover the animal's eyes with a protective ophthalmic ointment to keep the eyes moist during anesthesia. This will also suppress the animal's blink reflex, which can add noise to the recording.
-
Position the mouse so the speaker is placed 10 cm from its left ear.Notes:
- Speakers for this setup were calibrated using an ACO Pacific 7017 microphone.
- The center of the speaker has to be aligned with the external auditory canal.
-
Note: Use clean forceps to lift and tense the skin.
- Check the impedance: If the impedance is over 5 Ohm, adjust the electrodes in the scalp and retake the measurement. Continue to manipulate the electrodes until the impedance drops below 5 Ohm.
- Close the sound-proof chamber.
-
Sounds are presented and ABRs are recorded in a free field condition as previously described (Akil et al., 2015; Akil et al., 2012; Akil et al., 2006).Note: To measure each ear separately, as opposed to a sound free field ABR, a tube with an ear tip can be run from the speaker to the ear canal directly (close field), and the process above repeated.
-
-
Recording click auditory brainstem responses
TDT software (BioSig III) and hardware (RP and TD speakers) are used for ABR recording.-
TDT BioSigIII system, produces and records stimuli for 20 ms duration and 31 Hz. For click stimulus, in which the mouse is presented with a wide spectrum click (0.1 ms) in decreasing levels between 90 dB and 10 dB, each new stimulus is recorded 5 dB SPL down from the previous. Each point of measurement is recorded and averaged 510 times and analyzed.Notes:
- ABR results can be affected by other electronics in the sound-proof chamber - turn off extraneous transmitting electronic devices in the chamber, and ensure that the heating pad under the mouse is non-electric.
- Animal temperature - monitor the body temperature with a rectal probe throughout recording and keep the mouse’s body temperature warm using a heating pad (Gold et al., 1985).
-
Continue recording ABR until waveforms are clearly no longer present.Notes:
- If the middle ear, cochlea or brainstem is not functioning properly, waveforms will not be recorded (Figure 3 shows a sample of ABR waveforms from a wild-type (normal) and deaf mouse).
- The median ABR threshold in wild-type mice can vary depending on the system (TDT or Harvard Apparatus) and the method (close or free field) used to collect it. In general the ABR thresholds are ~ 30 ± 5 dB SPL.
- Read the result and determine the ABR threshold value, or the lowest level an identifiable waveform can be seen.
- The threshold can be determined by watching the first 5 peaks.
- All five peaks should be seen within the first 10 milliseconds.
- The ABR threshold is determined as the lowest recognizable ABR response (Figure 3: Black arrow).
- Save the resulting waveforms for future reference and analysis.
-
- Recording frequency-specific auditory brainstem responses
- When recording frequency-specific ABRs, three frequencies are classically tested to examine the degree to which regions of the cochlea are functioning (corresponding to base, mid-turn and apex), though in principle any specific frequency can be measured. Tone burst stimuli of 3 single frequencies (1 ms), including 8 kHz, 16 kHz, and 32 kHz are presented in decreasing levels between 90 dB and 10 dB. Each new stimulus is recorded 5 dB SPL down from the previous presentation. Each point of measurement is recorded and averaged 1,000 times and analyzed.
- ABR threshold is determined as the lowest recognizable ABR response similar to what it was described above.
-
Save the resulting waveforms for future reference and analysis.Notes:
- In general a mouse will remain under anesthesia for ~ 30-40 min after the first anesthetic injection.
- Due to the duration of click and frequency-specific ABR recordings (~ 40 min), one fifth of the original dose of the anesthetic should be injected at around 20 min to avoid the likelihood of the mouse waking up during the testing.
- If a mouse starts moving, the ABR recording will be disrupted and the mouse must be re-anesthetized with one fifth of the original anesthetic dose.
- When finished recording, carefully remove the electrode from the mouse.
- When all the tests are finished, dip the electrodes in Providone-iodine solution for about an hour; rinse with 70% ethanol then cap them and place them in a sterile container.
- Clean the recording chamber and all surfaces that were in contact with mice with 70% ethanol.
- Recovery from anesthesia
-
Place the mouse in an empty and clean preheated cage during emergence from anesthesia. Do not leave mice unattended until they are fully recovered. Place this cage on a heating pad to maintain the mouse’s body temperature until total recovery from the anesthesia has occurred.Note: Multiple mice of the same group can be placed in the same cage (no more than 5 mice).
- Return mice to their original cage without heating pad only if they can return themselves to their feet after being placed on their backs.
-
Representative data
Recipes
-
Mixture of ketamine hydrochloride and xylazine hydrochloride
It contains ketamine hydrochloride (Ketaset 100 mg/kg) and xylazine hydrochloride (Xyla-Ject 10 mg/kg):
2 ml ketamine (100 mg/ml)
1 ml xylazine (20 mg/ml)
5 ml sterile bi-distilled water
Mix well and place in a rubber sealed vial.
Notes:- The solution of ketamine and xylazine can be used as long as the ketamine or xylazine are not expired and are sterile.
- The solution should be stored at 4 °C when it is not in use and at room temperature when it is in use.
Acknowledgments
The authors would like to acknowledge the financial support provided by Hearing Research Inc (HRI) and by NIH (NIDCD) Grant #R01DC0130671.
References
- 1.Akil O, Chang J, Hiel H, Kong JH, Yi E, Glowatzki E, Lustig LR. Progressive deafness and altered cochlear innervation in knock-out mice lacking prosaposin. J Neurosci. 2006;26(50):13076–13088. doi: 10.1523/JNEUROSCI.3746-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Akil O, Seal RP, Burke K, Wang C, Alemi A, During M, Edwards RH, Lustig LR. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron. 2012;75(2):283–293. doi: 10.1016/j.neuron.2012.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Akil O, Sun Y, Vijayakumar S, Zhang W, Ku T, Lee CK, Jones S, Grabowski GA, Lustig LR. Spiral ganglion degeneration and hearing loss as a consequence of satellite cell death in saposin B-deficient mice. J Neurosci. 2015;35(7):3263–3275. doi: 10.1523/JNEUROSCI.3920-13.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Burkard RF, Eggermont JJ, Manuel D, editors. Auditory evoked potentials: basic principles and clinical application. Lippincott Williams & Wilkins; Philadelphi: 2007. [Google Scholar]
- 5.Gold S, Cahani M, Sohmer H, Horowitz M, Shahar A. Effects of body temperature elevation on auditory nerve-brain-stem evoked responses and EEGs in rats. Electroencephalogr Clin Neurophysiol. 1985;60(2):146–153. doi: 10.1016/0013-4694(85)90021-5. [DOI] [PubMed] [Google Scholar]
- 6.Zhou X, Jen PH, Seburn KL, Frankel WN, Zheng QY. Auditory brainstem responses in 10 inbred strains of mice. Brain Res. 2006;1091(1):16–26. doi: 10.1016/j.brainres.2006.01.107. [DOI] [PMC free article] [PubMed] [Google Scholar]